Related Experiment Video
Updated: Jun 3, 2026

Immunohistochemical Visualization of Hippocampal Neuron Activity After Spatial Learning in a Mouse Model of Neurodevelopmental Disorders
Published on: May 12, 2015
IGF1 molecular anomalies demonstrate its critical role in fetal, postnatal growth and brain development
Irène Netchine1, Salah Azzi, Yves Le Bouc
1APHP, Hôpital Armand-Trousseau, Explorations Fonctionnelles Endocriniennes, Paris, France. irene.netchine@trs.aphp.fr
Insights
Genetic defects in insulin-like growth factor-I (IGF-I) cause rare growth retardation, deafness, and intellectual deficits. Early diagnosis and recombinant IGF-I treatment are crucial for managing this condition.
Area of Science:
- Genetics
- Endocrinology
- Developmental Biology
Background:
- Human genetic insulin-like growth factor-I (IGF-I) defects lead to a rare syndrome.
- This syndrome is characterized by intrauterine and postnatal growth retardation, sensorineural deafness, and intellectual deficit.
Purpose of the Study:
- To describe the phenotype associated with human genetic IGF-I defects.
- To highlight the importance of IGF-I signaling for normal growth and brain development.
Main Methods:
- Clinical case descriptions and genetic analysis of affected individuals.
- Review of reported cases and clinical features.
Main Results:
- The syndrome includes growth retardation, sensorineural deafness, and intellectual deficit.
- Additional features can include microcephaly, adiposity, insulin resistance, gonadal dysfunction, and osteoporosis.
- Autosomal recessive inheritance is caused by homozygous mutations in the IGF1 gene.
Conclusions:
- Integrity of IGF-I signaling is essential for normal growth and brain development.
- Recombinant IGF-I is an available treatment option for patients with IGF-I deficiency.
Abstract:
The phenotype caused by human genetic insulin-like growth factor-I (IGF-I) defects is characterised by the association of intrauterine and postnatal growth retardation with sensorineural deafness and intellectual deficit. This syndrome is extremely rare and only four cases have been reported. Addition clinical features may include microcephaly and later in life adiposity and insulin resistance. Partial gonadal dysfunction and osteoporosis may also be present. A case of partial IGF-I deficiency has recently been described and was associated with pre- and postnatal growth retardation and microcephaly but the developmental delay was mild and hearing tests were normal. IGF-I deficiency is transmitted as an autosomal recessive trait and is caused by homozygous mutations in the IGF1 gene. Currently these patients can benefit from recombinant IGF-I which is now available for treatment. These observations demonstrate that the integrity of IGF-I signalling is important for normal growth and brain development.
Related Concept Videos
TGF - β Signaling Pathway
Teratogenicity
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Regulation of Angiogenesis and Blood Supply
Hedgehog Signaling Pathway

